Efficacy and safety of adding rivaroxaban to the anti-platelet regimen in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
about
Efficacy and safety of adding rivaroxaban to the anti-platelet regimen in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Efficacy and safety of adding ...... randomized controlled trials.
@en
Efficacy and safety of adding ...... randomized controlled trials.
@nl
type
label
Efficacy and safety of adding ...... randomized controlled trials.
@en
Efficacy and safety of adding ...... randomized controlled trials.
@nl
prefLabel
Efficacy and safety of adding ...... randomized controlled trials.
@en
Efficacy and safety of adding ...... randomized controlled trials.
@nl
P2860
P1476
Efficacy and safety of adding ...... f randomized controlled trials
@en
P2093
P2860
P2888
P356
10.1186/S40360-018-0209-2
P50
P577
2018-05-02T00:00:00Z
P6179
1103769111